Abtrace
Abtrace builds machine learning software for primary care that integrates with EMIS and SystmOne to detect disease deterioration and automate patient monitoring and recall across UK GP practices.
Abtrace is a London-based health-tech company founded in 2018 that builds machine learning systems for primary care. Its flagship product is proactive monitoring and intelligent recall software: an automated, self-learning care system that integrates with the EMIS and SystmOne electronic health record systems used across the United Kingdom. The software continuously scans patient records to detect signals of deterioration, early onset of new disease and opportunities for preventative intervention, while automating disease monitoring and recall processes.
The company operates at meaningful scale within the NHS ecosystem. Its software supports more than 250 GP practices and covers 4.5 million patients across 30 Integrated Care Boards. Technical work spans clinical AI, predictive health monitoring, preventative care analytics, disease deterioration detection and EHR integration.
Abtrace raised €2.4M in seed funding in 2021. It was founded by clinician-entrepreneurs, including Dr. Umar Naeem Ahmad, combining clinical and technical expertise. Digital Health Rewired has named it one of the hottest scale-ups in digital health. Its stated focus is on reducing administrative burden in primary care and improving patient safety.